Literature DB >> 22370599

Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma.

Jamie N Bakkum-Gamez1, Carrie L Langstraat, Janice R Martin, Maureen A Lemens, Amy L Weaver, Sumer Allensworth, Sean C Dowdy, William A Cliby, Bobbie S Gostout, Karl C Podratz.   

Abstract

OBJECTIVE: Thorough primary cytoreduction for epithelial ovarian carcinoma (EOC) improves survival. The incidence of postoperative ileus (POI) in these patients may be underreported because of varying POI definitions and the evolving, increasingly complex contemporary surgical approach to EOC. We sought to determine the current incidence of POI and its risk factors in women undergoing debulking and staging for EOC. <br> METHODS: We retrospectively identified the records of women who underwent primary staging and cytoreduction for EOC between 2003 and 2008. POI was defined as a surgeon's diagnosis of POI, return to nothing-by-mouth status, or reinsertion of a nasogastric tube. Perioperative patient characteristics and process-of-care variables were analyzed. Univariate analyses were used to identify POI risk factors; variables with P ≤.20 were included in multivariate analysis. <br> RESULTS: Among 587 women identified, the overall incidence of POI was 30.3% (25.9% without bowel resection, 38.5% with bowel resection; P=.002). Preoperative thrombocytosis, involvement of bowel mesentery with carcinoma, and perioperative red blood cell transfusion were independently associated with increased POI. Postoperative ibuprofen use was associated with decreased POI risk. Women with POI had a longer length of stay (median, 11 vs 6 days) and increased time to recovery of the upper (7.5 vs 4 days) and lower (4 vs 3 days) gastrointestinal tract (P<.001 for each). <br> CONCLUSIONS: The rate of POI is substantial among women undergoing staging and cytoreduction for EOC and is associated with increased length of stay. Modifiable risk factors may include transfusion and postoperative ibuprofen use. Alternative interventions to decrease POI are needed.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22370599      PMCID: PMC3909668          DOI: 10.1016/j.ygyno.2012.02.027

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  38 in total

1.  Causes of increased hospital stay after radical cystectomy in a clinical pathway setting.

Authors:  Sam S Chang; Roxelyn G Baumgartner; Nancy Wells; Michael S Cookson; Joseph A Smith
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

Review 2.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.

Authors:  Paul A Carless; David A Henry; Jeffrey L Carson; Paul Pc Hebert; Brian McClelland; Katharine Ker
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

3.  The effect of accelerated rehabilitation on recovery after surgery for ovarian malignancy.

Authors:  Charlotte Marx; Tina Rasmussen; Dorthe Hjort Jakobsen; Christian Ottosen; Lene Lundvall; Bent Ottesen; Torben Callesen; Henrik Kehlet
Journal:  Acta Obstet Gynecol Scand       Date:  2006       Impact factor: 3.636

4.  Advantages of fast-track recovery after laparoscopic right hemicolectomy for colon cancer.

Authors:  Vassiliki L Tsikitis; Stefan D Holubar; Eric J Dozois; Robert R Cima; John H Pemberton; David W Larson
Journal:  Surg Endosc       Date:  2010-01-28       Impact factor: 4.584

5.  Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals.

Authors:  Bruce L Hall; Barton H Hamilton; Karen Richards; Karl Y Bilimoria; Mark E Cohen; Clifford Y Ko
Journal:  Ann Surg       Date:  2009-09       Impact factor: 12.969

6.  Postoperative ileus: a colonic problem?

Authors:  J H Woods; L W Erickson; R E Condon; W J Schulte; L F Sillin
Journal:  Surgery       Date:  1978-10       Impact factor: 3.982

7.  Postoperative ileus after para-aortic lymphadenectomy: a prospective study.

Authors:  A Fagotti; F Fanfani; A Ercoli; M A Giordano; G Sallustio; G Scambia
Journal:  Gynecol Oncol       Date:  2006-08-21       Impact factor: 5.482

8.  Maximal cytoreductive effort in epithelial ovarian cancer surgery.

Authors:  Karin K Shih; Dennis S Chi
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

9.  Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer.

Authors:  N Gillette-Cloven; R A Burger; B J Monk; D S McMeekin; S Vasilev; P J DiSaia; M F Kohler
Journal:  J Am Coll Surg       Date:  2001-12       Impact factor: 6.113

10.  Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome.

Authors:  Farr R Nezhat; Mohammad Ezzati; Linus Chuang; Alireza A Shamshirsaz; Jamal Rahaman; Herb Gretz
Journal:  Am J Obstet Gynecol       Date:  2008-11-18       Impact factor: 8.661

View more
  10 in total

1.  Incidence and predictors of venous thromboembolism after debulking surgery for epithelial ovarian cancer.

Authors:  Bahareh Mokri; Andrea Mariani; John A Heit; Amy L Weaver; Michaela E McGree; Janice R Martin; Maureen A Lemens; William A Cliby; Jamie N Bakkum-Gamez
Journal:  Int J Gynecol Cancer       Date:  2013-11       Impact factor: 3.437

2.  The impact of perioperative packed red blood cell transfusion on survival in epithelial ovarian cancer.

Authors:  Lindsay L Morgenstern Warner; Sean C Dowdy; Janice R Martin; Maureen A Lemens; Michaela E McGree; Amy L Weaver; Karl C Podratz; Jamie N Bakkum-Gamez
Journal:  Int J Gynecol Cancer       Date:  2013-11       Impact factor: 3.437

Review 3.  New therapeutic strategies for postoperative ileus.

Authors:  Sjoerd H W van Bree; Andrea Nemethova; Cathy Cailotto; Pedro J Gomez-Pinilla; Gianluca Matteoli; Guy E Boeckxstaens
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-17       Impact factor: 46.802

4.  Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma.

Authors:  Collette R Lessard-Anderson; Kathryn S Handlogten; Rochelle J Molitor; Sean C Dowdy; William A Cliby; Amy L Weaver; Jennifer St Sauver; Jamie N Bakkum-Gamez
Journal:  Gynecol Oncol       Date:  2014-10-12       Impact factor: 5.482

5.  Utility of closed suction pelvic drains at time of large bowel resection for ovarian cancer.

Authors:  Eleftheria Kalogera; Sean C Dowdy; Andrea Mariani; Giovanni Aletti; Jamie N Bakkum-Gamez; William A Cliby
Journal:  Gynecol Oncol       Date:  2012-05-20       Impact factor: 5.482

6.  Risk factors and indications for 30-day readmission after primary surgery for epithelial ovarian cancer.

Authors:  Mariam AlHilli; Carrie Langstraat; Christine Tran; Janice Martin; Amy Weaver; Michaela McGree; Andrea Mariani; William Cliby; Jamie Bakkum-Gamez
Journal:  Int J Gynecol Cancer       Date:  2015-02       Impact factor: 3.437

7.  Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin.

Authors:  Qia Xu; Yun Liu; Shenyi Wang; Jing Wang; Liwei Liu; Yin Xu; Yide Qin
Journal:  BMC Cancer       Date:  2022-06-08       Impact factor: 4.638

8.  Risk-scoring model for prediction of non-home discharge in epithelial ovarian cancer patients.

Authors:  Mariam M AlHilli; Christine W Tran; Carrie L Langstraat; Janice R Martin; Amy L Weaver; Michaela E McGree; Andrea Mariani; William A Cliby; Jamie N Bakkum-Gamez
Journal:  J Am Coll Surg       Date:  2013-06-29       Impact factor: 6.113

9.  PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.

Authors:  Xiu Wang; Wanxing Duan; Xuqi Li; Jiangbo Liu; Donghong Li; Lianhong Ye; Lu Qian; Aijun Yang; Qinhong Xu; Han Liu; Qiaoshan Fu; Erxi Wu; Qingyong Ma; Xin Shen
Journal:  Oncotarget       Date:  2015-12-01

10.  Enhanced Recovery after Surgery Protocol Accelerates Recovery of Lumbar Disc Herniation among Elderly Patients Undergoing Discectomy via Promoting Gastrointestinal Function.

Authors:  Xiaohai Zuo; Linbang Wang; Longzhu He; Pei Li; Dandan Zhou; Yiping Yang
Journal:  Pain Res Manag       Date:  2021-11-22       Impact factor: 3.037

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.